256
Views
8
CrossRef citations to date
0
Altmetric
Glaucoma (Including Anterior Chamber)

Yellow Filter Effect on Melatonin Secretion in the Eye: Role in IOP Regulation

, &
Pages 614-618 | Received 19 Oct 2018, Accepted 07 Jan 2019, Published online: 24 Jan 2019

References

  • Lerner AB, Case JD, Takahashi Y. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J Biol Chem. 1960;235:1992–97.
  • Bubenik GA, Brown GM, Uhlir I, Grota LJ. Immunohistological localization of N-acetylindolealkylamines in pineal gland, retina and cerebellum. Brain Res. 1974;81:233–42.
  • Aimoto T, Rohde BH, Chiou GC, Lauber JK. N-acetyltransferase activity and melatonin level in the eyes of glaucomatous chickens. J Ocul Pharmacol. 1985;1:149–60.
  • Quay WB. Increases in volume, fluid content, and lens weight of eyes following systemic administration of melatonin. J Pineal Res. 1984;1:3–13.
  • Abe M, Itoh MT, Miyata M, Shimizu K, Sumi Y. Circadian rhythm of serotonin N -acetyltransferase activity in rat lens. Exp Eye Res. 2000;70(6):805–08. doi:10.1006/exer.2000.0845.
  • Mhatre MC, van Jaarsveld AS, Reiter RJ. Melatonin in the lacrimal gland: first demonstration and experimental manipulation. Biochem Biophys Res Commun. 1988;153:1186–92.
  • Crooke A, Guzman-Aranguez A, Mediero A, Alarma-Estrany P, Carracedo G, Pelaez T, Peral A, Pintor J. Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor. Curr Eye Res. 2015;40(1):56–65. doi:10.3109/02713683.2014.914540.
  • Bardak Y, Ozerturk Y, Ozguner F, Durmus M, Delibas N. Effect of melatonin against oxidative stress in ultraviolet-B exposed rat lens. Curr Eye Res. 2000;20:225–30.
  • Ali T, Badshah H, Kim TH, Kim MO. Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model. J Pineal Res. 2015;58(1):71–85. doi:10.1111/jpi.12194.
  • Blasiak J, Reiter RJ, Kaarniranta K. Melatonin in retinal physiology and pathology: the case of age-related macular degeneration. Oxid Med Cell Longev. 2016;2016:6819736. doi:10.1155/2016/6819736.
  • Crooke A, Colligris B, Pintor J. Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues. Curr Med Chem. 2012;19:3508–22.
  • Crooke A, Huete-Toral F, Martinez-Aguila A, Martin-Gil A, Pintor J. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma. J Pharmacol Exp Ther. 2013;346(1):138–45. doi:10.1124/jpet.112.202036.
  • Casson RJ, Chidlow G, Wood JP, Crowston JG, Goldberg I. Definition of glaucoma: clinical and experimental concepts. Clin Exp Ophthalmol. 2012;40(4):341–49. doi:10.1111/j.1442-9071.2012.02773.x.
  • Quigley HA. Glaucoma. Lancet. 2011;377(9774):1367–77. doi:10.1016/S0140-6736(10)61423-7.
  • Topouzis F, Harris A, Wilson MR, Koskosas A, Founti P, Yu F, Anastasopoulos E, Pappas T, Coleman AL. Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki eye study. Am J Ophthalmol. 2009;148(4):606–13 e1. doi:10.1016/j.ajo.2009.03.024.
  • Provencio I, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD. A novel human opsin in the inner retina. J Neurosci. 2000;20(2):600–05. doi:10.1523/JNEUROSCI.20-02-00600.2000.
  • Panda S, Provencio I, Tu DC, Pires SS, Rollag MD, Castrucci AM, Pletcher MT, Sato TK, Wiltshire T, Andahazy M, et al. Melanopsin is required for non-image-forming photic responses in blind mice. Science. 2003;301(5632):525–27. doi:10.1126/science.1086179.
  • Provencio I. The hidden organ in your eyes. Sci Am. 2011;304:54–59.
  • Rollag MD, Berson DM, Provencio I. Melanopsin, ganglion-cell photoreceptors, and mammalian photoentrainment. J Biol Rhythms. 2003;18(3):227–34. doi:10.1177/0748730403018003005.
  • The medical and biological effects of light. Conference on medical and biological effects of light. New York City, October 31-November 2, 1984. Ann N Y Acad Sci. 1985;453:1–408.
  • Erren TC, Reiter RJ, Piekarski C. Light, timing of biological rhythms, and chronodisruption in man. Naturwissenschaften. 2003;90(11):485–94. doi:10.1007/s00114-003-0468-6.
  • Weitzman ED, Czeisler CA, Zimmerman JC, Moore-Ede MC. Biological rhythms in man: relationship of sleep-wake, cortisol, growth hormone, and temperature during temporal isolation. Adv Biochem Psychopharmacol. 1981;28:475–99.
  • Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP Jr., Vitiello MV, Zhdanova IV. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American academy of sleep medicine review. Sleep. 2007;30:1460–83.
  • Lucas RJ, Peirson SN, Berson DM, Brown TM, Cooper HM, Czeisler CA, Figueiro MG, Gamlin PD, Lockley SW, O’Hagan JB, et al. Measuring and using light in the melanopsin age. Trends Neurosci. 2014;37(1):1–9. doi:10.1016/j.tins.2013.10.004.
  • Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53:41–44.
  • Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry. 2006;59(6):502–07. doi:10.1016/j.biopsych.2005.07.006.
  • Leppamaki S. Light and mood therapy. Duodecim. 2005;121:2600–05.
  • Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 2005;10(8):647–63. quiz 72.
  • Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005;24(2):275–306. doi:10.1016/j.preteyeres.2004.08.002.
  • Organisciak DT, Vaughan DK. Retinal light damage: mechanisms and protection. Prog Retin Eye Res. 2010;29(2):113–34. doi:10.1016/j.preteyeres.2009.11.004.
  • Alkozi HA, Wang X, Perez de Lara MJ, Pintor J. Presence of melanopsin in human crystalline lens epithelial cells and its role in melatonin synthesis. Exp Eye Res. 2016;154:168–176.
  • Alkozi HA, Pintor J. TRPV4 activation triggers the release of melatonin from human non-pigmented ciliary epithelial cells. Exp Eye Res. 2015;136:34–37. doi:10.1016/j.exer.2015.04.019.
  • Pintor J. Light-induced ATP release from the lens. Purinergic Signal. 2018. doi:10.1007/s11302-018-9626-3.
  • Ichikawa K; investigators Cs. Changes in blood pressure and sleep duration in patients with blue light-blocking/yellow-tinted intraocular lens (CHUKYO study). Hypertens Res. 2014;37(7):659–64. doi:10.1038/hr.2014.50.
  • Huete-Toral F, Crooke A, Martinez-Aguila A, Pintor J. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther. 2015;352(1):119–28. doi:10.1124/jpet.114.218263.
  • Pintor H. Improving melatonin delivery within the eye. J Bioequiv Availab. 2017;9:516–17.
  • Abe M, Itoh MT, Miyata M, Ishikawa S, Sumi Y. Detection of melatonin, its precursors and related enzyme activities in rabbit lens. Exp Eye Res. 1999;68(2):255–62. doi:10.1006/exer.1998.0601.
  • Alkozi HA, Perez de Lara MJ, Pintor J. Melatonin synthesis in the human ciliary body triggered by TRPV4 activation: involvement of AANAT phosphorylation. Exp Eye Res. 2017;162:1–8. doi:10.1016/j.exer.2017.06.018.
  • Sanderson J, Dartt DA, Trinkaus-Randall V, Pintor J, Civan MM, Delamere NA, Fletcher EL, Salt TE, Grosche A, Mitchell CH. Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Muller cells, lens, trabecular meshwork, cornea and lacrimal gland. Exp Eye Res. 2014;127:270–79. doi:10.1016/j.exer.2014.08.009.
  • Pintor J. Pharmacology without drugs. J Optom. 2018;11(4):201–02. doi:10.1016/j.optom.2018.06.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.